Assefa Ayenew, Kiros Teklehaimanot, Delelegn Birtukan
Unit of Immunology, Department of Medical Laboratory Science, Debre Tabor University, Debre Tabor, Ethiopia.
Unit of Medical Microbiology, Department of Medical Laboratory Science, Debre Tabor University, Debre Tabor, Ethiopia.
Int J Microbiol. 2023 Jul 31;2023:2282673. doi: 10.1155/2023/2282673. eCollection 2023.
Infections with the hepatitis B virus (HBV) and the hepatitis C virus (HCV) are worldwide problems that particularly place a heavy burden on developing nations. HBV and HCV infections during pregnancy have a high rate of vertical transmission and harmful consequences for both the mother and the child. Therefore, this study was carried out to assess the seroprevalence and associated factors of HBV and HCV infections among pregnant women attending antenatal care at Debre Tabor Comprehensive Specialized Hospital in Ethiopia.
A cross-sectional study was conducted from March 15 to September 16, 2022, at the Debre Tabor Comprehensive Specialized Hospital antenatal care clinic. Five milliliters of venous blood were collected from 422 pregnant women selected using a simple random sampling method. Data on sociodemographic characteristics and risk factors were collected using a prestructured questionnaire. A chi-square test, bivariate, and multivariate analyses were used to evaluate the association between dependent and independent variables. values less than 0.05 were considered statistically significant.
The seroprevalence of HBV and HCV infections was found to be 13% and 0.5%, respectively. Undertaking blood transfusion (AOR = 14.2, CI = 5.81-34.526, = 0.001), tattooing (AOR = 3.99, CI = 1.1-14.36, = 0.034), and dental therapy (AOR = 4.9, CI = 1.41-17.025, = 0.012) were significantly associated with HBV infection.
HBV infection in pregnant women was shown to have a high endemicity (13%) in this investigation, whereas the seroprevalence of HCV infection was low (0.5%). HBV infection was significantly associated with a history of blood transfusions, tattooing, and dental therapy. Screening pregnant women for HBV and HCV infections and providing effective therapy would ensure better outcomes for the newborn. In addition, health education must be used to increase knowledge of screening and modes of transmission.
乙型肝炎病毒(HBV)和丙型肝炎病毒(HCV)感染是全球性问题,尤其给发展中国家带来沉重负担。孕期HBV和HCV感染垂直传播率高,对母婴均有不良后果。因此,本研究旨在评估埃塞俄比亚德布雷塔博尔综合专科医院接受产前检查的孕妇中HBV和HCV感染的血清流行率及相关因素。
2022年3月15日至9月16日在德布雷塔博尔综合专科医院产前检查门诊进行了一项横断面研究。采用简单随机抽样方法从422名孕妇中采集5毫升静脉血。使用预先构建的问卷收集社会人口学特征和危险因素数据。采用卡方检验、双变量和多变量分析来评估因变量和自变量之间的关联。P值小于0.05被认为具有统计学意义。
HBV和HCV感染的血清流行率分别为13%和0.5%。接受输血(调整后比值比[AOR]=14.2,可信区间[CI]=5.81 - 34.526,P = 0.001)、纹身(AOR = 3.99,CI = 1.1 - 14.36,P = 0.034)和牙科治疗(AOR = 4.9,CI = 1.41 - 17.025,P = 0.012)与HBV感染显著相关。
本调查显示孕妇中HBV感染具有高流行率(13%),而HCV感染的血清流行率较低(0.5%)。HBV感染与输血史、纹身和牙科治疗史显著相关。对孕妇进行HBV和HCV感染筛查并提供有效治疗将确保新生儿有更好的结局。此外,必须通过健康教育来增加对筛查和传播方式的认识。